Monitoring the neutrophil-to-lymphocyte ratio may be useful for predicting the anticancer effect of nivolumab in recurrent or metastatic head and neck cancer
Keyword(s):
2020 ◽
2020 ◽
Vol 106
(5)
◽
pp. 1174
Keyword(s):
2015 ◽
Vol 59
(4)
◽
pp. 514-519
◽
Keyword(s):
2020 ◽
Vol 11
(3)
◽
pp. 417-422
◽
Keyword(s):
2018 ◽
Vol 36
(15_suppl)
◽
pp. 6038-6038
◽
Keyword(s):
Keyword(s):